These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14686878)

  • 1. N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.
    Tsuboi K; Hilligsmann C; Vandevoorde S; Lambert DM; Ueda N
    Biochem J; 2004 Apr; 379(Pt 1):99-106. PubMed ID: 14686878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A second N-acylethanolamine hydrolase in mammalian tissues.
    Ueda N; Tsuboi K; Lambert DM
    Neuropharmacology; 2005 Jun; 48(8):1079-85. PubMed ID: 15910884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages.
    Sun YX; Tsuboi K; Zhao LY; Okamoto Y; Lambert DM; Ueda N
    Biochim Biophys Acta; 2005 Oct; 1736(3):211-20. PubMed ID: 16154384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase.
    Saturnino C; Petrosino S; Ligresti A; Palladino C; De Martino G; Bisogno T; Di Marzo V
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1210-3. PubMed ID: 20022504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase.
    Yamano Y; Tsuboi K; Hozaki Y; Takahashi K; Jin XH; Ueda N; Wada A
    Bioorg Med Chem; 2012 Jun; 20(11):3658-65. PubMed ID: 22542283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Tsuboi K; Takezaki N; Ueda N
    Chem Biodivers; 2007 Aug; 4(8):1914-25. PubMed ID: 17712833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
    Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
    Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
    Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
    Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance.
    Ueda N; Yamanaka K; Yamamoto S
    J Biol Chem; 2001 Sep; 276(38):35552-7. PubMed ID: 11463796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.
    Wang X; Sarris K; Kage K; Zhang D; Brown SP; Kolasa T; Surowy C; El Kouhen OF; Muchmore SW; Brioni JD; Stewart AO
    J Med Chem; 2009 Jan; 52(1):170-80. PubMed ID: 19072118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies.
    Tsuboi K; Zhao LY; Okamoto Y; Araki N; Ueno M; Sakamoto H; Ueda N
    Biochim Biophys Acta; 2007 May; 1771(5):623-32. PubMed ID: 17462942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
    Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
    J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening for the discovery of inhibitors of fatty acid amide hydrolase using a microsome-based fluorescent assay.
    Wang Y; Ramirez F; Krishnamurthy G; Gilbert A; Kadakia N; Xu J; Kalgaonkar G; Ramarao MK; Edris W; Rogers KE; Jones PG
    J Biomol Screen; 2006 Aug; 11(5):519-27. PubMed ID: 16760367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical characterization and in vitro activity of AZ513, a noncovalent, reversible, and noncompetitive inhibitor of fatty acid amide hydrolase.
    Scott CW; Tian G; Yu XH; Paschetto KA; Wilkins DE; Meury L; Cao CQ; Varnes J; Edwards PD
    Eur J Pharmacol; 2011 Sep; 667(1-3):74-9. PubMed ID: 21645511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
    Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase.
    Vandevoorde S; Tsuboi K; Ueda N; Jonsson KO; Fowler CJ; Lambert DM
    J Med Chem; 2003 Oct; 46(21):4373-6. PubMed ID: 14521402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
    Deplano A; Karlsson J; Svensson M; Moraca F; Catalanotti B; Fowler CJ; Onnis V
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):815-823. PubMed ID: 32200655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase.
    Tsuboi K; Sun YX; Okamoto Y; Araki N; Tonai T; Ueda N
    J Biol Chem; 2005 Mar; 280(12):11082-92. PubMed ID: 15655246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates.
    Muccioli GG; Fazio N; Scriba GK; Poppitz W; Cannata F; Poupaert JH; Wouters J; Lambert DM
    J Med Chem; 2006 Jan; 49(1):417-25. PubMed ID: 16392827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors.
    Minkkilä A; Myllymäki MJ; Saario SM; Castillo-Melendez JA; Koskinen AM; Fowler CJ; Leppänen J; Nevalainen T
    Eur J Med Chem; 2009 Jul; 44(7):2994-3008. PubMed ID: 19232787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.